The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells
Abstract
Ovarian cancer is one of the most common cancers among women. Recent studies demonstrated that the gene encoding the p110α catalytic subunit of phosphatidylinositol 3-kinase (PI3K) is frequently amplified in ovarian cancer cells. PI3K is involved in multiple cellular functions, including proliferation, differentiation, antiapoptosis, tumorigenesis, and angiogenesis. In this study, we demonstrate that the inhibition of PI3K activity by LY-294002 inhibited ovarian cancer cell proliferation and induced G 1 cell cycle arrest. This effect was accompanied by the decreased expression of G 1-associated proteins, including cyclin D1, cyclin-dependent kinase (CDK) 4, CDC25A, and retinoblastoma phosphorylation at Ser 780, Ser 795, and Ser 807/811. Expression of CDK6 and β-actin was not affected by LY-294002. Expression of the cyclin kinase inhibitor p16 INK4a was induced by the PI3K inhibitor, whereas steady-state levels of p21 CIP1/WAF1 were decreased in the same experiment. The inhibition of PI3K activity also inhibited the phosphorylation of AKT and p70S6K1, but not extracellular regulated kinase 1/2. The G 1 cell cycle arrest induced by LY-294002 was restored by the expression of active forms of AKT and p70S6K1 in the cells. Our study shows that PI3K transmits a mitogenic signal through AKT and mammalian target of rapamycin (mTOR) to p70S6K1. The mTOR inhibitor rapamycin had similar inhibitory effects on G 1 cell cycle progression and on the expression of cyclin D1, CDK4, CDC25A, and retinoblastoma phosphorylation. These results indicate that PI3K mediates G 1 progression and cyclin expression through activation of an AKT/mTOR/p70S6K1 signaling pathway in the ovarian cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
PIK3CA is implicated as an oncogene in ovarian cancer
Shayesteh, L., Lu, Y., Kuo, W.-L., Baldocchi, R., Godfrey, T., Collins, C., Pinkel, D., Powell, B., Mills, G. B., & Gray, J. W. (1999) · Nature Genetics · doi:10.1038/5042 · Cited by 1,155
Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation
COFFER, P. J., JIN, J., & WOODGETT, J. R. (1998) · Biochemical Journal · doi:10.1042/bj3350001 · Cited by 1,067
D-type cyclin-dependent kinase activity in mammalian cells.
Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., & Kato, J. Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2066 · Cited by 1,064
Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
Reynisdóttir, I., Polyak, K., Iavarone, A., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.15.1831 · Cited by 962
Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k
Jefferies, H. B. J., Fumagalli, S., Dennis, P. B., Reinhard, C., Pearson, R. B., & Thomas, G. (1997) · The EMBO Journal · doi:10.1093/emboj/16.12.3693 · Cited by 934
The Regulation and Activities of the Multifunctional Serine/Threonine Kinase Akt/PKB
Kandel, E. S., & Hay, N. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4690 · Cited by 869
Identification of G1 kinase activity for cdk6, a novel cyclin D partner.
Meyerson, M., & Harlow, E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2077 · Cited by 794
Chan, T. O., Rittenhouse, S. E., & Tsichlis, P. N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.965 · Cited by 737
p21-containing cyclin kinases exist in both active and inactive states.
Zhang, H., Hannon, G. J., & Beach, D. (1994) · Genes & Development · doi:10.1101/gad.8.15.1750 · Cited by 632
Purification and characterization of phosphoinositide 3-kinase from rat liver.
Carpenter, C. L., Duckworth, B. C., Auger, K. R., Cohen, B., Schaffhausen, B. S., & Cantley, L. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)45429-9 · Cited by 627
Jiang, B.-H., Zheng, J. Z., Aoki, M., & Vogt, P. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040560897 · Cited by 528
Self-citationAssociation of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase.
Chen, H. C., & Guan, J. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.10148 · Cited by 513
Muise-Helmericks, R. C., Grimes, H. L., Bellacosa, A., Malstrom, S. E., Tsichlis, P. N., & Rosen, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29864 · Cited by 511
Transformation of Chicken Cells by the Gene Encoding the Catalytic Subunit of PI 3-Kinase
Chang, H. W., Aoki, M., Fruman, D., Auger, K. R., Bellacosa, A., Tsichlis, P. N., Cantley, L. C., Roberts, T. M., & Vogt, P. K. (1997) · Science · doi:10.1126/science.276.5320.1848 · Cited by 412
Phosphatidylinositol 3-Kinase Couples the Interleukin-2 Receptor to the Cell Cycle Regulator E2F
Brennan, P., Babbage, J. W., Burgering, B. M. T., Groner, B., Reif, K., & Cantrell, D. A. (1997) · Immunity · doi:10.1016/s1074-7613(00)80388-x · Cited by 404
Li, Y., Nichols, M. A., Shay, J. W., & Xiong, Y. (1994) · PubMed · Cited by 359
Induction of ovarian cancer by defined multiple genetic changes in a mouse model system
Orsulic, S., Li, Y., Soslow, R. A., Vitale-Cross, L. A., Gutkind, J. S., & Varmus, H. E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(01)00002-2 · Cited by 358
Parry, D., Bates, S., Mann, D. J., & Peters, G. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07026.x · Cited by 354
The Prognostic Significance of Altered Cyclin-Dependent Kinase Inhibitors in Human Cancer
Tsihlias, M., Kapusta, M., & Slingerland, M. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.401 · Cited by 319
Hu, L., Zaloudek, C. J., Mills, G. B., Gray, J. W., & Jaffe, R. B. (2000) · PubMed · Cited by 301
The Akt kinase: Molecular determinants of oncogenicity
Aoki, M., Batista, O., Bellacosa, A., Tsichlis, P., & Vogt, P. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14950 · Cited by 296
Dufourny, B., Alblas, J., van Teeffelen, H. A. A. M., van Schaik, F. M. A., van der Burg, B., Steenbergh, P. H., & Sussenbach, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.31163 · Cited by 257
Role of E2F in cell cycle control and cancer
Johnson, D. G. (1998) · Frontiers in Bioscience · doi:10.2741/a291 · Cited by 224
Glycogen Synthase Kinase-3 Couples AKT-dependent Signaling to the Regulation of p21Cip1 Degradation
Rössig, L., Badorff, C., Holzmann, Y., Zeiher, A. M., & Dimmeler, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106157200 · Cited by 218
Grewe, M., Gansauge, F., Schmid, R. M., Adler, G., & Seufferlein, T. T. W. (1999) · PubMed · Cited by 209
Coordinate regulation of translation by the PI 3-kinase and mTOR pathways
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)86001-8 · Cited by 199
Downstream Signalling Events Regulated by Phosphatidylinositol 3-Kinase Activity
Duronio, V., Scheid, M. P., & Ettinger, S. (1998) · Cellular Signalling · doi:10.1016/s0898-6568(97)00129-0 · Cited by 192
The v-Src SH3 domain binds phosphatidylinositol 3'-kinase.
Liu, X., Marengere, L. E., Koch, C. A., & Pawson, T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5225 · Cited by 178
Seufferlein, T., & Rozengurt, E. (1996) · PubMed · Cited by 169
Viñals, F., Chambard, J. C., & Pouysségur, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.26776 · Cited by 165
S6 Phosphorylation and the p70 s6k /p85 s6k
Ferrari, S. M., & Thomas, G. (1994) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239409083485 · Cited by 146
Schreiber, M., Muller, W. J., Singh, G., & Graham, F. L. (1999) · Oncogene · doi:10.1038/sj.onc.1202466 · Cited by 145
Interleukin-2 Triggers a Novel Phosphatidylinositol 3-Kinase-Dependent MEK Activation Pathway
Karnitz, L. M., Burns, L. A., Sutor, S. L., Blenis, J., & Abraham, R. T. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3049 · Cited by 142
Mitsuuchi, Y., Johnson, S. W., Selvakumaran, M., Williams, S. J., Hamilton, T. C., & Testa, J. R. (2000) · PubMed · Cited by 137
Structural and functional analysis of pp70S6k.
Cheatham, L. A., Monfar, M., Chou, M. M., & Blenis, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11696 · Cited by 125
Kanda, S., Hodgkin, M. N., Woodfield, R. J., Wakelam, M. J. O., Thomas, G., & Claesson, L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.37.23347 · Cited by 93
Pellegatta, F., Chierchia, S. L., & Zocchi, M. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.27768 · Cited by 80
Romanelli, A., Dreisbach, V. C., & Blenis, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205168200 · Cited by 78
Casagrande, F., Bacqueville, D., Pillaire, M., Malecaze, F., Manenti, S., Breton, M., & Darbon, J.-M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00043-x · Cited by 74
Swarbrick, A., Lee, C. S. L., Sutherland, R. L., & Musgrove, E. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2581-2591.2000 · Cited by 71
Mahalingam, M., & Templeton, D. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.1.405 · Cited by 63
Association of phosphatidylinositol 3-kinase with SHC in chronic myelogeneous leukemia cells.
Harrison-Findik, D. D., Susa, M., & Varticovski, L. (1995) · PubMed · Cited by 63
Wages, D. S., Keefer, J. R., Rall, T. B., & Weber, M. J. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.1866-1874.1992 · Cited by 60
Izuhara, K., Feldman, R. A., Greer, P. A., & Harada, N. (1996) · Blood · doi:10.1182/blood.v88.10.3910.bloodjournal88103910 · Cited by 50
In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer.
Modesitt, S. C., Ramírez, P. J., Zu, Z., et al. (2001) · PubMed · Cited by 46
Yu, J., Liu, X.-W., & Kim, H.-R. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309986200 · Cited by 38
Gaben, A., Saucier, C., Bedin, M., Barbu, V., & Mešter, J. (2003) · International Journal of Cancer · doi:10.1002/ijc.11521 · Cited by 35
Kivinen, L., & Laiho, M. (1999) · PubMed · Cited by 34
Hsing (1996) · doi:10.1002/(sici)1097-0215(19960208)65:4 · Cited by 1
Cited by
mTOR and cancer: insights into a complex relationship
Sabatini, D. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1974 · Cited by 1,322
PI3K-Akt pathway: Its functions and alterations in human cancer
Osaki, M., Oshimura, M., & Ito, H. (2004) · Apoptosis · doi:10.1023/b:appt.0000045801.15585.dd · Cited by 1,264
Pharmacologic Characterization of a Potent Inhibitor of Class I Phosphatidylinositide 3-Kinases
Raynaud, F. I., Eccles, S., Clarke, P. A., Hayes, A., Nutley, B., Alix, S., Henley, A., Di-Stefano, F., Ahmad, Z., Guillard, S., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4615 · Cited by 352
PI3K/PTEN signaling in tumorigenesis and angiogenesis
Jiang, B.-H., & Liu, L.-Z. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.09.008 · Cited by 345
Self-citationTargeting cell signaling in allergic asthma
Athari, S. S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0079-0 · Cited by 312
Metadata
- Authors
- Gao, N., Flynn, D. C., Zhang, Z., Zhong, X.-S., Walker, V., Liu, K. J., Shi, X., & Jiang, B.-H.
- Venue
- American Journal of Physiology-Cell Physiology
- Publisher
- American Physiological Society
- Published
- 2004-08
- Volume
- 287
- Issue
- 2
- Pages
- C281-C291
- ISSN
- 0363-6143 (ISSN-L)
- 1522-1563
- OpenAlex
- W2008205044
- Cited by
- 307
- References
- 54
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.